Startup to Acquisition in 2 Years: Grove AI’s Journey to Transform Clinical Trials
Summary
Grove AI built AI voice agents to automate clinical trial recruitment for pharma companies, CROs, and trial sites. The startup launched in 2024, raised $4.9 million in seed funding, and then got acquired by Hippocratic AI in January for an undisclosed amount. Its technology helps patients find and screen for trials through phone, text, and multilingual conversations instead of clunky manual forms. The company now plans to extend its agents beyond recruitment into post-enrollment and post-approval support for patients and clinicians.
AskAI Classifications
Sectors
HealthTech
Health Analytics
Clinical Software
Functions
Developer and IT Infrastructure
Development Platforms
Workflow Orchestration
Linked Companies
Hippocratic AI
$10M to $25M
Grove AI
$1M to $5M